Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum

Journal of the American Society of Nephrology

Volumn 12, Issue 10, 2001, Pages 2146-2157

  Combet, S ^a   Ferrier, M L ^a   Van Landschoot, M ^a   Stoenoiu, M ^a   Moulin, P ^a   Miyata, T ^a   Lameire, N ^a   Devuyst, O ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROSIS; KIDNEY FAILURE; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SEROSA; STRUCTURE ANALYSIS; UREMIA;

EID: 0034821966     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Peritoneal dialysis
2. The peritoneal membrane in chronic peritoneal dialysis
3. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients
4. Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD
5. Growth factors VEGF and TGF-beta 1 in peritoneal dialysis
6. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis
7. Pathophysiology of uremia
8. Nitric oxide and vascular disease
9. Total nitric oxide production is low in patients with chronic renal disease
10. Nitric oxide production is reduced in patients with chronic renal failure
11. Renal and systemic nitric oxide synthesis in rats with renal mass reduction
12. Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients
13. Renal synthesis of arginine in chronic renal failure: In vivo and in vitro studies in rats with 5/6 nephrectomy
14. The impact of chronic renal failure on nitric oxide synthase isoforms gene expression in the penis and pelvic ganglia of rats
15. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
16. Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking
17. Subtotal nephrectomy: A mosaic of growth factors
18. Cardiac remodeling in experimental renal failure: An immunohistochemical study
19. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats
20. Experimental models in peritoneal dialysis: A European experience
21. Experimental models of nephron reduction: Some answers, many questions
22. Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis
23. A specific method for measurement of nitric oxide synthase enzymatic activity in peritoneal biopsies
24. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions
25. β2-microglobulin modified with advanced glycation and products is a major component of hemodialysis-associated amyloidosis
26. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD
27. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways
28. Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis
29. Role of arginine in health and in renal disease
30. The physiology of peritoneal solute transport and ultrafiltration
31. Reduced capillary density in the myocardium of uremic rats - A stereological study
32. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
33. The FGF family of growth factors and oncogenes
34. Biological roles of fibroblast growth factor-2
35. Expression of fetal kidney growth factors in a kidney tumor line: Role of FGF2 in kidney development
36. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation
37. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis
38. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo
39. Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia
40. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO
41. Endothelial cell responses to hypoxic stress
42. Progression of renal disease and renal hypertrophy
43. A comparison of peritoneal transport in patients with psoriasis and uremia